As of 2024-12-11, the Fair Value of Ikena Oncology Inc (IKNA) is -5.45 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.70 USD, the upside of Ikena Oncology Inc is -420.87%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -16.82 | -44.26 | -34.12 | -68.77 | -68.17 | -46.43 |
| YoY growth | 58.85% | -163.14% | 22.91% | -101.55% | 0.88% | -36.41% |
| Market Cap (mil) | 92.87 |
| P/E | |
| Forward P/E |
| EPS | -1.09 |
| Avg earnings growth rate | -36.41% |
| TTM earnings | -59.60 |